ARS Pharmaceuticals, Inc.
SPRY • NASDAQ
ARS Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard E. Lowenthal, with a market cap of $821.2M.
Market Cap$821.2M
Employees24.0
CEORichard E. Lowenthal
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
ARS Pharmaceuticals, Inc. FAQ
Common questions about ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026. Analysts estimate revenue of $23.3M.
ARS Pharmaceuticals, Inc. has approximately 24 employees.